These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8061931)

  • 41. [Reduction of the UV dose in combined dithranol-UV therapy of psoriasis].
    Bárta U; Schaarschmidt H
    Dermatol Monatsschr; 1985; 171(2):91-4. PubMed ID: 3979628
    [No Abstract]   [Full Text] [Related]  

  • 42. Alteration of the expression of Bcl-2, Bcl-x, Bax, Fas, and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy.
    Yamamoto T; Nishioka K
    Skin Pharmacol Appl Skin Physiol; 2003; 16(1):50-8. PubMed ID: 12566829
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Psoriasis: diagnosis and therapy].
    Panizzon R
    Praxis (Bern 1994); 1995 May; 84(22):649-53. PubMed ID: 7784768
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of fumaric acid esters and dithranol on acanthosis and hyperproliferation in psoriasis vulgaris.
    Bacharaçh-Buhles M; Röchling A; el Gammal S; Altmeyer P
    Acta Derm Venereol; 1996 May; 76(3):190-3. PubMed ID: 8800297
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Leukotrienes and monohydroxy fatty acids: controversial role in the pathogenesis of psoriasis].
    Ruzicka T
    Hautarzt; 1985 May; 36(5):255-8. PubMed ID: 2989218
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Item 123-- Psoriasis].
    CEDEF
    Ann Dermatol Venereol; 2012 Oct; 139(11 Suppl):A112-20. PubMed ID: 23176831
    [No Abstract]   [Full Text] [Related]  

  • 47. Cytotoxic T lymphocytes as a potential brake of keratinocyte proliferation in psoriasis.
    Vičić M; Peternel S; Simonić E; Sotošek-Tokmadžić V; Massari D; Brajac I; Kaštelan M; Prpić-Massari L
    Med Hypotheses; 2016 Feb; 87():66-8. PubMed ID: 26826643
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-cytokine therapy in the treatment of psoriasis.
    Kupetsky EA; Mathers AR; Ferris LK
    Cytokine; 2013 Mar; 61(3):704-12. PubMed ID: 23410503
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidermal differentiation characteristics of the psoriatic plaque during short contact treatment with dithranol cream.
    van der Vleuten CJ; de Jong EM; van de Kerkhof PC
    Clin Exp Dermatol; 1996 Nov; 21(6):409-14. PubMed ID: 9167334
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PUVA combination therapy.
    Morison WL
    Photodermatol; 1985 Aug; 2(4):229-36. PubMed ID: 3903677
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phototherapy and dithranol treatment of psoriasis: new lamps for old.
    Farr PM; Diffey BL; Marks JM
    Br Med J (Clin Res Ed); 1987 Jan; 294(6566):205-7. PubMed ID: 3101812
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Psoriasis vulgaris].
    Umezawa Y; Ozawa A
    Ryoikibetsu Shokogun Shirizu; 2000; (31):293-5. PubMed ID: 11269084
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of short-contact anthralin therapy on ultraviolet B irradiation of psoriasis.
    Boer J; Smeenk G
    J Am Acad Dermatol; 1986 Aug; 15(2 Pt 1):198-204. PubMed ID: 3745524
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes.
    Albanesi C; De Pità O; Girolomoni G
    Clin Dermatol; 2007; 25(6):581-8. PubMed ID: 18021896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Calcitriol vs. dithranol in combination with narrow-band ultraviolet B (311 nm) in psoriasis.
    Hofmann UB; Eggert AA; Bröcker EB; Goebeler M
    Br J Dermatol; 2003 Apr; 148(4):779-83. PubMed ID: 12752138
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aetiology and pathogenesis of psoriasis.
    Ortonne JP
    Br J Dermatol; 1996 Oct; 135 Suppl 49():1-5. PubMed ID: 9035700
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Demonstration and functional analysis of IL-10 receptors in human epidermal cells: decreased expression in psoriatic skin, down-modulation by IL-8, and up-regulation by an antipsoriatic glucocorticosteroid in normal cultured keratinocytes.
    Michel G; Mirmohammadsadegh A; Olasz E; Jarzebska-Deussen B; Müschen A; Kemény L; Abts HF; Ruzicka T
    J Immunol; 1997 Dec; 159(12):6291-7. PubMed ID: 9550434
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CCL7 contributes to the TNF-alpha-dependent inflammation of lesional psoriatic skin.
    Brunner PM; Glitzner E; Reininger B; Klein I; Stary G; Mildner M; Uhrin P; Sibilia M; Stingl G
    Exp Dermatol; 2015 Jul; 24(7):522-8. PubMed ID: 25828150
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Antipsoriatic effect of dithranol (anthralin). 1].
    Raab W
    Hautarzt; 1975 Sep; 26(9):452-5. PubMed ID: 1184389
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel therapies for psoriasis.
    Cather J; Menter A
    Am J Clin Dermatol; 2002; 3(3):159-73. PubMed ID: 11978137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.